A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of Oral HRS5091 in Healthy Subjects and Chronic Hepatitis B Patients
Clinical trial NCT04480294 · UNKNOWN
Trial details
- NCT number
- NCT04480294
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-28
- Primary completion
- 2021-11-23
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.